Longitudinal increase in γ-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men

Metabolism: Clinical and Experimental

Volumn 59, Issue 5, 2010, Pages 683-689

  Ryu, Seungho ^a   Chang, Yoosoo ^a   Woo, Hee Yeon ^a   Yoo, Sang Ho ^b   Choi, Nam Kyong ^c   Lee, Won Young ^a   Kim, Inah ^d   Song, Jaechul ^e  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Eulji University   (South Korea)

^e Hanyang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; ECHOGRAPHY; ENZYME BLOOD LEVEL; EXERCISE; FATTY LIVER; FOLLOW UP; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; COHORT STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN; KOREA; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; TRIGLYCERIDES; URIC ACID;

EID: 77950623253     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.08.024     Document Type: Article

References (35)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
2. Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92 (2007) 399-404
3. Laaksonen D.E., Lakka H.M., Niskanen L.K., et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156 (2002) 1070-1077
4. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
5. Gami A.S., Witt B.J., Howard D.E., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49 (2007) 403-414
6. Sonnenberg G.E., Krakower G.R., and Kissebah A.H. A novel pathway to the manifestations of metabolic syndrome. Obes Res 12 (2004) 180-186
7. Whitfield J.B. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38 (2001) 263-355
8. Franzini M., Corti A., Martinelli B., et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques-biochemical similarities with the circulating enzyme. Atherosclerosis 202 (2009) 119-127
9. Paolicchi A., Emdin M., Ghliozeni E., et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 109 (2004) 1440
10. Lee D.H., Ha M.H., Kim J.H., et al. Gamma-glutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia 46 (2003) 359-364
11. Lee D.H., Jacobs Jr. D.R., Gross M., et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49 (2003) 1358-1366
12. Lee D.S., Evans J.C., Robins S.J., et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27 (2007) 127-133
13. Ryu S., Chang Y., Kim D.I., et al. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 53 (2007) 71-77
14. Meisinger C., Doring A., Schneider A., et al. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189 (2006) 297-302
15. Jousilahti P., Rastenyte D., and Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 31 (2000) 1851-1855
16. Andre P., Balkau B., Vol S., et al. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care 30 (2007) 2355-2361
17. Rantala A.O., Lilja M., Kauma H., et al. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med 248 (2000) 230-238
18. Nilssen O., and Forde O.H. Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromso Study. Am J Epidemiol 139 (1994) 787-792
19. Chang Y., Ryu S., Sung E., et al. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 53 (2007) 686-692
20. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
21. Kojima S., Watanabe N., Numata M., et al. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 38 (2003) 954-961
22. Wen C.P., David Cheng T.Y., Tsai S.P., et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr 12 (2009) 497-506
23. Kalbfleisch J.D., and Prentice R.L. The statistical analysis of failure time data. 2nd edn. (2002), Wiley Interscience, Hoboken, NJ
24. Grundy S.M. Gamma-glutamyl transferase: another biomarker for metabolic syndrome and cardiovascular risk. Arterioscler Thromb Vasc Biol 27 (2007) 4-7
25. Nakanishi N., Suzuki K., and Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27 (2004) 1427-1432
26. Wallace T.M., Utzschneider K.M., Tong J., et al. Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat. Diabetes Care 30 (2007) 2673-2678
27. Lee D.H., and Jacobs Jr. D.R. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 178 (2005) 327-330
28. Yamada J., Tomiyama H., Yambe M., et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 189 (2006) 198-205
29. Lee D.H., Blomhoff R., and Jacobs Jr. D.R. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 38 (2004) 535-539
30. Pompella A., Emdin M., Passino C., et al. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med 42 (2004) 1085-1091
31. Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004) 1752-1761
32. Stevens J., Couper D., Pankow J., et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res 9 (2001) 696-705
33. Wei M., Gaskill S.P., Haffner S.M., et al. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans-a 7-year prospective study. Obes Res 5 (1997) 16-23
34. Lee D.H., Gross M.D., and Jacobs Jr. D.R. Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study. Clin Chem 50 (2004) 582-588
35. Lee D.H., Steffes M.W., and Jacobs Jr. D.R. Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes?. Diabetologia 51 (2008) 402-407